(Q43000510)

English

Successful treatment with novel triple drug combination consisting of interferon-gamma, interferon alfacon-1, and ribavirin in a nonresponder HCV patient to pegylated interferon therapy

scientific article published in May 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Successful treatment with novel triple drug combination consisting of interferon-gamma, interferon alfacon-1, and ribavirin in a nonresponder HCV patient to pegylated interferon therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1 reference

based on heuristic

inferred from title

pegylated interferon

1 reference

based on heuristic

inferred from title

author name string

Vijayan Balan

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Marianne J Rosati

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Machiko H Anderson

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Jorge Rakela

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

1 May 2006

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Digestive Diseases and Sciences

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

51

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

956-959

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

NIH conference. Immunomodulators in clinical medicine

1 reference

https://api.crossref.org/works/10.1007%2FS10620-006-9349-0

21 January 2018

EORTC (30885) randomised phase III study with recombinant interferon alpha and recombinant interferon alpha and gamma in patients with advanced renal cell carcinoma. The EORTC Genitourinary Group

1 reference

https://api.crossref.org/works/10.1007%2FS10620-006-9349-0

21 January 2018

High-dose methotrexate in combination with interferons in the treatment of malignant pleural mesothelioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16758306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs

1 reference

https://pubmed.ncbi.nlm.nih.gov/16758306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The biologic activity and molecular characterization of a novel synthetic interferon-alpha species, consensus interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/16758306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alpha- and gamma-interferon versus alpha-interferon alone in chronic hepatitis B. A randomized controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16758306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy of chronic hepatitis B with recombinant human alpha and gamma interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/16758306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/16758306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary results of the alternating administration of natural interferon-alpha and recombinant interferon-gamma for metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16758306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferons combined with chemotherapy in the treatment of stage III-IV non-small cell lung cancer--a randomised study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16758306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined alpha- and gamma-interferon therapy for malignant midgut carcinoid tumors. A phase I-II trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16758306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16758306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/16758306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10620-006-9349-0

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43000510&oldid=2205735470"